NCT01797718View on ClinicalTrials.gov

Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 20, 2017

Study Completion Date

February 5, 2018

Conditions
Constitutional Delay of Growth and Puberty
Interventions
DRUG

Testosterone

1mg/kg every 4 weeks for 6 months

DRUG

Letrozole

2.5mg daily for 6 months. Safety criteria: if testosterone level is above 30nM at 3 months, the dosage is reduced to 2.5mg every other day

Trial Locations (4)

20521

Turku University Central Hospital, Turku

70211

Kuopio University Central Hospital, Kuopio

00029

Helsinki University Central Hospital, Helsinki

Unknown

Kotka Central Hospital, Kotka

All Listed Sponsors
collaborator

Foundation for Paediatric Research, Finland

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT01797718 - Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment | Biotech Hunter | Biotech Hunter